Myeloproliferative Neoplasms (MPNs) program

Myeloproliferative Neoplasms (MPNs) program

Myeloproliferative neoplasms (MPNs) are stem cell disorders affecting blood and bone marrow in which there is uncontrolled production of blood cells. Patients with MPNs can develop an aggressive form of leukemia, also known as acute myeloid leukemia. 

Thanks to a generous gift of $2.4 million from Elizabeth and Tony Comper, the Princess Margaret Cancer Centre established the Myeloproliferative Neoplasm Program (MPN), the first of its kind in Canada.

This kick-started the development of a state-of-the-art MPN Program at The Princess Margaret. The Elizabeth and Tony Comper MPN Program has become a centre of excellence in MPN research and patient care, both nationally and internationally, with an aim to bring together Canadian cancer centres to make MPN patient care and research a nationwide priority.